BeStock  
Stocks › Medical Devices › TMDX

TransMedics TMDX

US equityMarket cap rank #2438Medical Devices
$85.25 −$8.77 (-9.33%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $85.60 +0.41%
Open$90.81
Prev close$94.02
Day range$83.89 – $91.62
Volume1.59M
Market cap$2.96B
P/E (TTM)23.2
Dividend yield–

TMDX Stock News

Headlines matching TransMedics or the TMDX ticker, most recent first.

  • Needham Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $106Market news · 22 Sep 2026 · Direct mention
  • Piper Sandler Maintains TransMedics(TMDX.US) With Buy Rating, Cuts Target Price to $90 NegativeMarket news · 2 Sep 2026 · Direct mention
  • Piper Sandler Maintains TransMedics(TMDX.US) With Buy Rating, Raises Target Price to $100 PositiveMarket news · 12 Sep 2026 · Direct mention
  • GUIDANCE: (TMDX) TransMedics Expects Full Year 2026 Revenue Range $737M - $757M, Vs. FactSet Est of $743.1MMT Newswires · 11 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for TransMedics(TMDX.US), With a Forecast Between $95 to $106Market news · 11 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for TransMedics(TMDX.US), With a Forecast Between $95 to $122Market news · 5 Aug 2026 · Direct mention
  • Needham Maintains TransMedics(TMDX.US) With Buy Rating, Cuts Target Price to $106 NegativeMarket news · 3 Aug 2026 · Direct mention
  • TransMedics (TMDX): Buy Rating Backed by Accelerating U.S. Organ Transplant Volumes and Expanding OCS UtilizationTipRanks · 3 Aug 2026 · Direct mention
  • Oppenheimer Maintains TransMedics(TMDX.US) With Hold RatingMarket news · 24 Aug 2026 · Direct mention
  • CCORF Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $95Market news · 13 Aug 2026 · Direct mention
  • Piper Sandler Maintains TransMedics(TMDX.US) With Buy Rating, Cuts Target Price to $120 NegativeMarket news · 7 Jul 2026 · Direct mention
  • Evercore Maintains TransMedics(TMDX.US) With Buy Rating, Cuts Target Price to $90 NegativeMarket news · 6 Jul 2026 · Direct mention
  • Piper Sandler Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $120Market news · 22 Jul 2026 · Direct mention
  • CCORF Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $124Market news · 30 Jun 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Aquestive Therapeutics (AQST) and Alto Neuroscience, Inc. (ANRO)TipRanks · 26 Jun 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on TMDX.

Sign in to join the discussion.

Scroll to Top